Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ANAB

AnaptysBio

$80.73

5.46 (7.25%)

04:55
06/19/18
06/19
04:55
06/19/18
04:55
Conference/Events
AnaptysBio management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Over a week ago
ANAB

AnaptysBio

$74.87

4.25 (6.02%)

06:51
06/15/18
06/15
06:51
06/15/18
06:51
Conference/Events
AnaptysBio management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

ANAB

AnaptysBio

$77.82

-4.82 (-5.83%)

, AIMT

Aimmune

$32.65

-0.55 (-1.66%)

08:56
05/29/18
05/29
08:56
05/29/18
08:56
Recommendations
AnaptysBio, Aimmune analyst commentary at JMP Securities »

JMP says AnaptysBio…

ANAB

AnaptysBio

$77.82

-4.82 (-5.83%)

AIMT

Aimmune

$32.65

-0.55 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 19

    Jun

ANAB

AnaptysBio

$77.82

-4.82 (-5.83%)

08:37
05/29/18
05/29
08:37
05/29/18
08:37
Hot Stocks
AnaptysBio says ANB019 well-tolerated by all subjects in Phase 1 trial »

AnaptysBio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 19

    Jun

ANAB

AnaptysBio

$77.82

-4.82 (-5.83%)

08:35
05/29/18
05/29
08:35
05/29/18
08:35
Hot Stocks
AnaptysBio says ANB020 generally well-tolerated by patients »

AnaptysBio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 19

    Jun

Over a month ago
CLVS

Clovis

$48.22

-1.71 (-3.42%)

, GILD

Gilead

$68.15

0.3 (0.44%)

04:55
05/24/18
05/24
04:55
05/24/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$48.22

-1.71 (-3.42%)

GILD

Gilead

$68.15

0.3 (0.44%)

PTLA

Portola Pharmaceuticals

$39.48

-0.71 (-1.77%)

DNLI

Denali Therapeutics

$20.33

0.32 (1.60%)

TBPH

Theravance Biopharma

$23.01

0.04 (0.17%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.70

0.1 (1.16%)

NKTR

Nektar

$82.81

0.87 (1.06%)

BMRN

BioMarin

$88.50

0.84 (0.96%)

RARE

Ultragenyx

$65.28

1.07 (1.67%)

EXEL

Exelixis

$20.59

-0.99 (-4.59%)

ANAB

AnaptysBio

$81.93

-4.25 (-4.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

CLVS

Clovis

$49.93

0.24 (0.48%)

, GILD

Gilead

$67.85

0.22 (0.33%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$49.93

0.24 (0.48%)

GILD

Gilead

$67.85

0.22 (0.33%)

PTLA

Portola Pharmaceuticals

$40.19

-0.76 (-1.86%)

DNLI

Denali Therapeutics

$20.01

0.32 (1.63%)

TBPH

Theravance Biopharma

$22.97

-0.03 (-0.13%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.60

-0.1 (-1.15%)

NKTR

Nektar

$81.94

-1.46 (-1.75%)

BMRN

BioMarin

$87.66

-1.69 (-1.89%)

RARE

Ultragenyx

$64.21

-0.55 (-0.85%)

EXEL

Exelixis

$21.58

0.64 (3.06%)

ANAB

AnaptysBio

$86.18

-0.72 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

CLVS

Clovis

$49.69

-0.43 (-0.86%)

, GILD

Gilead

$67.63

-0.38 (-0.56%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$49.69

-0.43 (-0.86%)

GILD

Gilead

$67.63

-0.38 (-0.56%)

PTLA

Portola Pharmaceuticals

$40.95

-0.45 (-1.09%)

DNLI

Denali Therapeutics

$19.69

-0.02 (-0.10%)

TBPH

Theravance Biopharma

$23.00

-1.27 (-5.23%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.70

-0.425 (-4.66%)

NKTR

Nektar

$83.40

-1.9 (-2.23%)

BMRN

BioMarin

$89.35

0.4 (0.45%)

RARE

Ultragenyx

$64.76

-1.17 (-1.77%)

EXEL

Exelixis

$20.94

-0.64 (-2.97%)

ANAB

AnaptysBio

$86.90

-0.52 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

CLVS

Clovis

$50.12

-1.89 (-3.63%)

, GILD

Gilead

$68.01

0.41 (0.61%)

07:15
05/21/18
05/21
07:15
05/21/18
07:15
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$50.12

-1.89 (-3.63%)

GILD

Gilead

$68.01

0.41 (0.61%)

PTLA

Portola Pharmaceuticals

$41.40

0.4 (0.98%)

DNLI

Denali Therapeutics

$19.71

0.72 (3.79%)

TBPH

Theravance Biopharma

$24.27

-0.19 (-0.78%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$9.13

0.025 (0.27%)

NKTR

Nektar

$85.30

6.075 (7.67%)

BMRN

BioMarin

$88.95

0.51 (0.58%)

RARE

Ultragenyx

$65.93

1.75 (2.73%)

EXEL

Exelixis

$21.58

0.02 (0.09%)

ANAB

AnaptysBio

$87.42

-1.92 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

ANAB

AnaptysBio

$88.52

-0.96 (-1.07%)

16:41
05/08/18
05/08
16:41
05/08/18
16:41
Earnings
AnaptysBio reports Q1 EPS (63c), consensus (44c) »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 21

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.